News – Portfolio

  • All
  • 2020
  • 2019
  • 2018

Neuro Event Labs Oy closes EUR 3.9m Series A investment round from Hadean Ventures, SHS Gesellschaft für Beteiligungsmanagement and

Pipeline Therapeutics Completes $30 Million Series B Financing

Hadean Ventures invests in Themis Bioscience GmbH EUR 40m Series D Financing round

Hadean Ventures leads 40 million SEK (€3.7 million) investment round into SAGA to advance ultrasensitive cancer liquid biopsies

Hadean Ventures, SINTEF Venture V and Investinor invest in Nisonic AS to develop advanced ultrasound technology for neurological conditions.

Hadean Ventures today announces an investment in AttgeNO AB, a Swedish pharmaceutical company developing treatments for acute life-threatening conditions.